NCT07629609
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Signet Ring Cell, +14 more
- Locations
-
- Rigshospitalet Copenhagen, Denmark
Clinical trial condition
Carcinoma, Signet Ring Cell
Explore clinical trials studying Carcinoma, Signet Ring Cell. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Carcinoma, Signet Ring Cell trial results
NCT06978595
- Conditions
- Adenocarcinoma, Cancer, Carcinoma, +17 more
- Locations
-
- Suez Canal University Ismailia, Egypt
NCT01249859
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Signet Ring Cell, +12 more
- Locations
-
- University Hospital of Lille Lille, France
Active, Not Recruiting
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
NCT02978625
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Anaplastic Large Cell Lymphoma, ALK-Positive, +86 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- Keck Medical Center of USC Pasadena Pasadena, California, United States
Active, Not Recruiting
METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer - Shaping Anti-Tumor Immunity by Oxaliplatin
NCT05504252
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Carcinoma, +8 more
- Locations
-
- Akershus University Hospital Lørenskog, Akershus, Norway
- Oslo University Hospital Oslo, Akershus, Norway
- St Olavs Hospital Trondheim, Trøndelag, Norway